MX2010000927A - Uso de analogos y derivados de la vitamina k para el tratamiento de transtornos y condiciones de enfermedad en humanos. - Google Patents
Uso de analogos y derivados de la vitamina k para el tratamiento de transtornos y condiciones de enfermedad en humanos.Info
- Publication number
- MX2010000927A MX2010000927A MX2010000927A MX2010000927A MX2010000927A MX 2010000927 A MX2010000927 A MX 2010000927A MX 2010000927 A MX2010000927 A MX 2010000927A MX 2010000927 A MX2010000927 A MX 2010000927A MX 2010000927 A MX2010000927 A MX 2010000927A
- Authority
- MX
- Mexico
- Prior art keywords
- vitamin
- analogues
- derivatives
- conditions
- treatment
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 229940046010 vitamin k Drugs 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 229930003448 Vitamin K Natural products 0.000 abstract 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 3
- 235000019168 vitamin K Nutrition 0.000 abstract 3
- 239000011712 vitamin K Substances 0.000 abstract 3
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 3
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 101000774651 Naja atra Zinc metalloproteinase-disintegrin-like kaouthiagin-like Proteins 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 206010048591 Post thrombotic syndrome Diseases 0.000 abstract 1
- 206010046996 Varicose vein Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000008081 blood perfusion Effects 0.000 abstract 1
- 201000002816 chronic venous insufficiency Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 210000002751 lymph Anatomy 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000027185 varicose disease Diseases 0.000 abstract 1
- 201000002282 venous insufficiency Diseases 0.000 abstract 1
- 208000004043 venous thromboembolism Diseases 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con los usos terapéuticos de la vitamina K, sus análogos y derivados en una gama diversa de condiciones de enfermedad. La vitamina K mejora la perfusión de la sangre y alivia la hipoxia en la prevención y tratamiento de afecciones como las manifestaciones de insuficiencia venosa crónica, síndrome post-traumático, afecciones de la piel relacionadas con la melanización, hiperpigmentación, Parestasia, edema, venas varicosas, VTE y calambres. La invención también proporciona composiciones farmacéuticas que comprenden la vitamina K, sus análogos, derivados o compuestos similares a la vitamina K solos o en combinación con uno o más agentes activos terapéuticamente efectivos para la enfermedad/afección de las venas, nervios y sistema linfático, que son abarcadas por esta invención.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1419MU2007 | 2007-07-24 | ||
| PCT/IN2008/000465 WO2009063485A2 (en) | 2007-07-24 | 2008-07-21 | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010000927A true MX2010000927A (es) | 2010-05-19 |
Family
ID=40639275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010000927A MX2010000927A (es) | 2007-07-24 | 2008-07-21 | Uso de analogos y derivados de la vitamina k para el tratamiento de transtornos y condiciones de enfermedad en humanos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100130618A1 (es) |
| EP (1) | EP2178818B1 (es) |
| KR (1) | KR20100042282A (es) |
| AU (1) | AU2008322224B2 (es) |
| BR (1) | BRPI0812686A2 (es) |
| CA (1) | CA2694318A1 (es) |
| MX (1) | MX2010000927A (es) |
| NZ (1) | NZ583069A (es) |
| RU (1) | RU2454997C2 (es) |
| WO (1) | WO2009063485A2 (es) |
| ZA (1) | ZA201001189B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9616127B2 (en) * | 2008-03-11 | 2017-04-11 | Livionex Inc. | Method and topical formulation for treating localized edema |
| CN102781258A (zh) * | 2009-09-14 | 2012-11-14 | 雀巢产品技术援助有限公司 | 包含外源性维生素k2的用于调节炎症的营养组合物 |
| US8580742B2 (en) | 2010-03-05 | 2013-11-12 | N.V. Perricone Llc | Topical glutathione formulations for menopausal skin |
| US8609604B2 (en) | 2009-12-28 | 2013-12-17 | N.V. Perricone Llc | Methods of improving the appearance of aging skin |
| US20110250157A1 (en) * | 2009-12-28 | 2011-10-13 | Perricone Nicholas V | Skin Hyperpigmentation Acyl Glutathione Treatments |
| BR112013009724A2 (pt) * | 2010-11-01 | 2016-07-19 | Viridis Biopharma Pvt Ltd | equilíbrio dinâmico do sistemna nervoso autonômo utilizando a vitamina mk-7 |
| CN103347505B (zh) * | 2011-02-14 | 2015-02-04 | J-制油株式会社 | 皮肤胶原蛋白增强剂 |
| JP5483786B1 (ja) * | 2012-07-24 | 2014-05-07 | 株式会社Ｊ−オイルミルズ | 組成物 |
| FR2995186A1 (fr) | 2012-09-13 | 2014-03-14 | Parc Inversions | Nouvel agent de salaison alimentaire hyposode |
| EP2886129A1 (en) * | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prevention and counteraction of diet-induced thrombosis risk |
| US9421297B2 (en) | 2014-04-02 | 2016-08-23 | Adhezion Biomedical, Llc | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides |
| WO2016120341A2 (en) | 2015-01-27 | 2016-08-04 | Vitak B.V. | Epidermal skin health |
| EP3258924A2 (en) | 2015-02-20 | 2017-12-27 | VitaK B.V. | Vitamin k and capillary function |
| US10493020B2 (en) | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
| AU2017274438A1 (en) * | 2016-06-02 | 2018-12-13 | Ana Pharmaceuticals, Inc. | Methods and compositions for treatment of hypercalciuria and nephrolithiasis |
| GB201702174D0 (en) | 2017-02-09 | 2017-03-29 | Benevolentai Bio Ltd | Orexin receptor antagonists |
| GB201707504D0 (en) | 2017-05-10 | 2017-06-21 | Benevolentai Bio Ltd | Orexin receptor antagonists |
| GB201707499D0 (en) | 2017-05-10 | 2017-06-21 | Benevolentai Bio Ltd | Orexin receptor antagonists |
| WO2019123144A1 (en) * | 2017-12-19 | 2019-06-27 | Synergia Life Sciences Pvt. Ltd. | Vitamin k2 compositions for the treatment of drug induced neuropathy |
| WO2019191773A1 (en) * | 2018-03-30 | 2019-10-03 | Kaydence Pharma As | Rapidly improving vascular conditions by administering vitamin k |
| CA3132245A1 (en) * | 2019-03-12 | 2020-09-17 | Kaydence Pharma As | Use of vitamin k in combination with anticoagulants |
| CN111920792A (zh) * | 2020-09-07 | 2020-11-13 | 南通大学 | 甲基萘醌-7在制备防治缺氧/缺血脑损伤疾病药物中的应用 |
| CN115154448B (zh) * | 2022-08-04 | 2024-01-30 | 谭竞 | 一种治疗不宁腿综合征的药物及其制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6374436B1 (en) * | 1994-01-25 | 2002-04-23 | Hill-Rom Services, Inc. | Hospital bed |
| AU2870992A (en) * | 1991-10-04 | 1993-05-03 | Board Of Regents Of The University Of Nebraska, The | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
| US5510391A (en) * | 1993-10-22 | 1996-04-23 | Mayapple Holdings, Llc | Method of treating blood vessel disorders of the skin using vitamin K |
| AU2804297A (en) * | 1996-04-22 | 1997-11-12 | Advanced Polymer Systems Inc. | Method of and composition for treating disorders of the skin using vitamin k |
| GB0016452D0 (en) * | 2000-07-04 | 2000-08-23 | Kilgowan Limited | Vitamin K and essential fatty acids |
| US6881419B2 (en) * | 2002-04-09 | 2005-04-19 | William E. Lovett | Vitamin formulation for enhancing bone strength |
| FR2843963B1 (fr) * | 2002-08-30 | 2004-10-22 | Sederma Sa | Nouvelles molecules derivees de la noraporphine |
| US20050271596A1 (en) * | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| EP1589930A2 (en) * | 2003-01-08 | 2005-11-02 | Flacco-Nesselroad Family Trust | Combination therapy for anticoagulation |
| CN100531727C (zh) * | 2003-01-20 | 2009-08-26 | 奥里格国际股份有限公司 | 含有维生素k1氧化物或其衍生物的组合物用于治疗和/或预防哺乳动物皮肤损害的用途 |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| WO2005030190A1 (en) * | 2003-09-26 | 2005-04-07 | Natural Asa | Natural menaquinone 7 compositions |
| RU2245717C1 (ru) * | 2003-12-16 | 2005-02-10 | Миронов Владимир Андреевич | Способ лечения кожных заболеваний |
| US7597676B2 (en) * | 2004-01-22 | 2009-10-06 | University Of Massachusetts | Malleolar pad |
| DE202004013521U1 (de) * | 2004-08-30 | 2006-01-05 | Almapharm Christian F.A. Botzenhardt Gmbh + Co | Präparat aus beta-Glucan und Nukleotid zur Verabreichung an Tiere |
| US20060275229A1 (en) * | 2005-05-17 | 2006-12-07 | Sreekumar Pillai | Skin care active complex and methods of using same |
-
2008
- 2008-07-21 AU AU2008322224A patent/AU2008322224B2/en active Active
- 2008-07-21 BR BRPI0812686-0A patent/BRPI0812686A2/pt not_active IP Right Cessation
- 2008-07-21 KR KR1020107003644A patent/KR20100042282A/ko not_active Application Discontinuation
- 2008-07-21 NZ NZ583069A patent/NZ583069A/en active IP Right Revival
- 2008-07-21 US US12/452,803 patent/US20100130618A1/en not_active Abandoned
- 2008-07-21 CA CA2694318A patent/CA2694318A1/en not_active Abandoned
- 2008-07-21 MX MX2010000927A patent/MX2010000927A/es not_active Application Discontinuation
- 2008-07-21 EP EP08848777.2A patent/EP2178818B1/en active Active
- 2008-07-21 WO PCT/IN2008/000465 patent/WO2009063485A2/en active Application Filing
- 2008-07-21 RU RU2010106031/15A patent/RU2454997C2/ru not_active IP Right Cessation
-
2010
- 2010-02-18 ZA ZA2010/01189A patent/ZA201001189B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2178818B1 (en) | 2020-09-09 |
| ZA201001189B (en) | 2010-11-24 |
| US20100130618A1 (en) | 2010-05-27 |
| EP2178818A2 (en) | 2010-04-28 |
| CA2694318A1 (en) | 2009-05-22 |
| WO2009063485A2 (en) | 2009-05-22 |
| AU2008322224B2 (en) | 2012-05-10 |
| WO2009063485A3 (en) | 2009-11-26 |
| EP2178818A4 (en) | 2010-07-28 |
| NZ583069A (en) | 2012-06-29 |
| BRPI0812686A2 (pt) | 2011-10-18 |
| KR20100042282A (ko) | 2010-04-23 |
| RU2454997C2 (ru) | 2012-07-10 |
| RU2010106031A (ru) | 2011-08-27 |
| AU2008322224A1 (en) | 2009-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010000927A (es) | Uso de analogos y derivados de la vitamina k para el tratamiento de transtornos y condiciones de enfermedad en humanos. | |
| CY1115245T1 (el) | Φαρμακευτικη συνθεση που συνδυαζει διαφορους φλεβοτονικους και αγγειοπροστατευτικους παραγοντες για τη θεραπεια χρονιας φλεβικης ανεπαρκειας | |
| NO20052625L (no) | Preparater for transdermal oksybutyninterapi. | |
| EA201170592A1 (ru) | Комбинированная терапия с применением пептид эпоксикетонов | |
| WO2009025763A3 (en) | Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues | |
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| EA201300522A1 (ru) | Фармацевтические комбинации для лечения метаболических нарушений | |
| EA201200762A1 (ru) | Применение простагландинов f2-альфа и аналогов для заживления повреждений роговицы и конъюнктивы | |
| WO2012006516A3 (en) | Protein kinase c activators and anticoagulant for the treatment of stroke | |
| AR075413A1 (es) | Composiciones y metodo para usar aminopiridinas metodo para tratar la esclerosis multiple | |
| EA200970944A1 (ru) | Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов | |
| JP2015521632A5 (es) | ||
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| WO2007070637A3 (en) | Method of treating open wounds using hypochlorous acid | |
| WO2012142615A3 (en) | Auranofin and auranofin analogs useful to treat proliferative disease and disorders | |
| WO2012135812A3 (en) | Treatment for dermatological pathologies | |
| PE20121700A1 (es) | Composicion que comprende l-carnitina o propionil l-carnitina, troxerutina, diosmina y hesperidina | |
| CR20160276A (es) | "piperidiniltetrahidroquinolinas sustituidas y su uso como antagonistas de los adenoreceptores alpha-2c" | |
| WO2014153385A3 (en) | Methods of treating metabolic disorders | |
| NO20075393L (no) | Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse | |
| MY158929A (en) | Pharmaceutical combination | |
| CR20160277A (es) | Piperidinil tetrahidroquinolinas sustituidas | |
| MX2014014818A (es) | Composicion farmaceutica para el tratamiento de enfermedades inflamatorias de la piel. | |
| WO2014070696A3 (en) | Treatment of chronic dermal inflammatory with norketotifen | |
| DE602004030048D1 (de) | Ffizienz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |